Contaminated dicloxacillin capsules as the source of an NDM-5/OXA-48-producing Enterobacter hormaechei ST79 outbreak, Denmark and Iceland, 2022 and 2023.

Charlotte Nielsen Agergaard, Lone Jannok Porsbo,Thomas Vognbjerg Sydenham,Sanne Grønvall Kjær Hansen,Kat Steinke,Sanne Løkkegaard Larsen,Kristján Orri Helgason,Frank Hansen,Kasper Thystrup Karstensen, Anna E Henius,Barbara Juliane Holzknecht, Lillian Søes,Kristian Schønning,Mikala Wang,Nina Ank,Anna Margrét Halldórsdóttir,Ólafur Guðlaugsson,Anette M Hammerum,Anne Kjerulf,Brian Kristensen,Henrik Hasman,Ulrik Stenz Justesen

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin（2023）

引用 0|浏览15

暂无评分

摘要

From October 2022 through January 2023, nine patients with NDM-5/OXA-48-carbapenemase-producing ST79 were detected in Denmark and subsequently one patient in Iceland. There were no nosocomial links between patients, but they had all been treated with dicloxacillin capsules. An NDM-5/OXA-48-carbapenemase-producing ST79, identical to patient isolates, was cultured from the surface of dicloxacillin capsules in Denmark, strongly implicating them as the source of the outbreak. Special attention is required to detect the outbreak strain in the microbiology laboratory.

查看译文

关键词

CPO,Enterobacter hormaechei,Outbreak,antibiotic,dicloxacillin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要